A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118) Article

cited authors

  • Knisely, Jonathan PS; Berkey, Brian; Chakravarti, Arnab; Yung, Al WK; Curran, Walter J; Robins, H Ian; Movsas, Benjamin; Brachman, David G; Henderson, Randall H; Mehta, Minesh P

fiu authors

publication date

  • May 1, 2008

keywords

  • ANGIOGENESIS INHIBITORS
  • APOPTOSIS
  • BEVACIZUMAB
  • CANCER
  • COMBINATION
  • Life Sciences & Biomedicine
  • NONSMALL CELL LUNG
  • Oncology
  • PROLIFERATION
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • RENAL-CELL
  • Science & Technology
  • antiangiogenesis
  • brain metastases
  • phase III trial
  • thalidomide
  • whole-brain radiotherapy

Digital Object Identifier (DOI)

start page

  • 79

issue

  • 1